The Director's Forum series is written and edited by Robert Weber and Scott Mark and is designed to guide pharmacy leaders in establishing patient-centered services in hospitals and health systems. As more pharmacy boards are approving and endorsing medication therapy, management directors of pharmacy will need to understand mechanisms for payment for these services. This article provides some initial information for pharmacy directors in developing a strategy for financial support of pharmacy cognitive services.
Agency for Healthcare Research and Quality. Chronic Disease: A greater number of different chronic conditions increases hospital readmissions and costs. August 2009. Available at: http://www.ahrq.gov/research/aug09/0809RA16.htm. Accessed February 10, 2010.
3.
BuntingB.A., CranorC.W.The Asheville project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc (2003).2006; 46(2): 133–147.
4.
FeraT., BlumlB.M., EllisW.M.Diabetes Ten City Challenge: final economic and clinical results. J Am Pharm Assoc (2003).2009; 49(3): 383–391.
5.
SnellaK.A., TrewynR.R., HansenL.B., BradberryJ.C.Pharmacist compensation for cognitive services: focus on the physician office and community pharmacy. Pharmacotherapy.2004; 24(3): 372–388.
6.
BarnettM.J., FrankJ., WehringH.. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm.2009; 15(1): 18–31.
7.
ThomasJ., ZingoneM.M., SmithJ., GeorgeC.M.Feasibility of contracting for medication therapy management services in a physician's office. Am J Health Syst Pharm.2009; 66(15): 1390–1393.
8.
SchommerJ.C., PlanasL.G., JohnsonK.A., DoucetteW.R.Pharmacist-provided medication therapy management (part 1): Provider perspectives in 2007. J Am Pharm Assoc (2003).2008; 48(3): 354–363.
9.
ChristensenD.Hospital-based ambulatory pharmacy services. In: VogenbergF.R., ed. Understanding Pharmacy Reimbursement.1st ed.Bethesda, MD: American Society of Health-System Pharmacists; 2006: 103.
American Pharmacists Association, National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc (2003).2008; 48(3): 341–353.
12.
Centers for Medicaid & Medicare Services. The Medicare Prescription Drug, Improvement, and Modernization Act. HR 1/ Pub. L. No. 108-173. Published December 8, 2003. Accessed 2010.
13.
US Department of Health & Human Services, Centers for Medicare & Medicaid Services. Memorandum to all Part D Sponsors: Contract year 2010 medication therapy management program (MTMP) submission. April 10, 2009.
14.
SnellaK.A., SachdevG.P.A primer for developing pharmacist-managed clinics in the outpatient setting. Pharmacotherapy.2003; 23(9): 1153–1166.
15.
Overview on National Provider Identifier Standard (NPI). Centers for Medicare & Medicaid Services Web site.http://www.cms.hhs.gov/NationalProvIdentStand. Updated October 28, 2009. Accessed February 10, 2010.
16.
ZingoneM.M., MalcolmK.E., McCormickS.W., BledsoeK.R.Analysis of pharmacist charges for medication therapy management services in an outpatient setting. Am J Health Syst Pharm.2007; 64(17): 1827–1831.
McMahanR.Operationalizing MTM through the use of health information technology. J Manag Care Pharm.2008; 14(2 Suppl):S18–21.
20.
MillonigM.K.Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings. J Am Pharm Assoc (2003).2009; 49(3): 372–382.
21.
IsettsB.J., SchondelmeyerS.W., ArtzM.B.. Clinical and economic outcomes of medication therapy management services: The Minnesota experience. J Am Pharm Assoc (2003).2008; 48(2): 203–211.
22.
HogueM.D., McDonoughR., BennettM., BrynerC., ThomasR.A.APhA Academy of Pharmacy Practice & Management Medication Therapy Management Task Force. Development of a medication therapy management superbill for ambulatory care/community pharmacy practice. J Am Pharm Assoc (2003).2009; 49(2): 232–236.
